Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antidepressant Effects of Cang-ai Volatile Oil
NCT07384312Completed
- Start
- Oct 2023
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of Cang-ai Volatile Oil in major depressive disorder (MDD) (2 arms). Primary endpoint: Relative concentration changes of oxyhemoglobin (HbO2) and deoxyhemoglobin (deoxy-Hb) at 1 month. Started Oct 2023; status: completed.
02
Drugs
Cang-ai Volatile Oil
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT07384312.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07384312.